கேந்ய ஹோண்டா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கேந்ய ஹோண்டா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கேந்ய ஹோண்டா Today - Breaking & Trending Today

Weight gain dramatically raises risk of digestive system diseases, researchers warn


Middle-aged spread dramatically raises the risk of digestive system cancers, researchers have warned.
The threat of a tumour developing in the stomach or liver soars 13 per cent for every extra unit of body mass index (BMI), according to a study.
And the likelihood of gullet and pancreatic cancer also increases by 10 and 6 per cent respectively.
Obesity is a major factor in all four types of the disease – and shedding the pounds can help prevent them, scientists said.
The study, carried out by British and Swedish researchers, analysed more than 350,000 people from the UK Biobank database.
They found that being tall was associated with a greater risk of all cancers investigated.  ....

City Of , United Kingdom , Amy Mason , Stephen Burgess , Cambridge University , Bristol University , Imperial College London , Tokyo Keio University , Stockholm Karolinska Institute , United Kingdom Biobank , Karolinska Institute , Kenya Honda , Keio University , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , ஆமி கொத்தனார் , ஸ்டீபன் பர்கஸ் , கேம்பிரிட்ஜ் பல்கலைக்கழகம் , பிரிஸ்டல் பல்கலைக்கழகம் , ஏகாதிபத்தியம் கல்லூரி லண்டன் , டோக்கியோ கேோ பல்கலைக்கழகம் , கேந்ய ஹோண்டா , கேோ பல்கலைக்கழகம் ,

The Microbiome Gains Momentum in Cancer Immunotherapy


The Microbiome Gains Momentum in Cancer Immunotherapy
The Microbiome Gains Momentum in Cancer Immunotherapy
Vedanta Biosciences develops drugs made from defined bacterial consortia. One of these drugs, a cancer drug called VE800, addresses a challenge that may commonly occur with microbiome-engaging cancer immunotherapeutics. The problem is variability in microbiome signatures. Vedanta’s CEO, Bernat Olle, PhD, says that with cancer, there is no “night and day type of signature” like that seen with Clostridium difficile infections. Olle suggests that overcoming this problem will require big data sets, big sample sizes, and multiomic analyses.
The Microbiome Gains Momentum in Cancer Immunotherapy ....

United States , Persephone Biosciences , Persephone Bio , Bristol Myers Squibb , Tim Lu , Stephanie Culler , William Coley , Aoife Brennan , Jim Collins , Bernat Olle , Jennifera Wargo , Integrative Medical Sciences , National Cancer Research Institute , Md Anderson Cancer Center , Nobel Prize , Cancer Conference , Cancer Center , Vedanta Biosciences , Kenya Honda , What Vedanta , Hamilton Microlab , Like Jason , Golden Fleece , ஒன்றுபட்டது மாநிலங்களில் , பர்ஸெயோந் உயிர் அறிவியல் , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் ,